Ankyra provides cancer therapy services that use tumor localized immune potentiating agents to boost anti-tumor immune responses. Their approach, called Anchored Immunotherapy, promotes prolonged immune activation locally while limiting systemic toxicity. This allows for systemic dosing of immune stimulants that were previously limited by broad immune activation and toxicity. Ankyra's goal is to provide cancer patients with an instant treatment for cancer without any surgery.